GetPortalImpactFactorByIdResp(projectId=1, id=d9e513096, cover=https://img.medsci.cn/images/journal/cover/2021/otU_202109271316068210.jpg, fullname=Molecular Therapy-Methods & Clinical Development, abbr=MOL THER-METH CLIN D, pyear=暂无数据, frequence=Irregular, articleNumbers=1026, citedSelf2015=5.4, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2.5月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2329-0501, greenSci=https://www.greensci.net/search?kw=2329-0501, scijournal=https://www.scijournal.org/impact-factor-of-MOL-THER-METH-CLIN-D.shtml, medsciHotlightString=null, medsciHotlightRealtime=1.947, medsciHotlight=4.115, medsciHotlight5year=2.78218, citescore=0.0, hIndex=32, impactFactor=4.7, orgnization=Cell Press, orgnizationUrl=, country=United States, countryCn=美国, isOa=1, isOaString=是, sciScie=, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=http://www.cell.com/molecular-therapy-family/methods/latest-content, websiteHits=2680, guideForAuthor=http://www.cell.com/pb-assets/journals/society/molecular-therapy/Authors_MTM.pdf, guideForAuthorHits=613, submitWebsite=https://www.editorialmanager.com/mtm/default.aspx, submitWebsiteHits=1126, content=<h2 style="margin: 1em 0px; font-size: 22px; line-height: normal; text-rendering: optimizeLegibility; font-stretch: normal; user-select: text !important; color: rgb(0, 63, 45) !important; font-family: Garamond, times, serif !important;">Molecular Therapy</h2><p style="margin: 0px 0px 1.2em; line-height: 1.4em; color: rgb(51, 51, 51); font-family: arial, sans-serif; font-size: 13px; user-select: text !important;"><em style="user-select: text !important;">Molecular Therapy </em>is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy''s 2015 impact factor is 6.938.</p><h2 style="margin: 1em 0px; font-size: 22px; line-height: normal; text-rendering: optimizeLegibility; font-stretch: normal; user-select: text !important; color: rgb(0, 63, 45) !important; font-family: Garamond, times, serif !important;">Molecular Therapy — Methods & Clinical Developments</h2><p style="margin: 0px 0px 1.2em; line-height: 1.4em; color: rgb(51, 51, 51); font-family: arial, sans-serif; font-size: 13px; user-select: text !important;">The aim of <em style="user-select: text !important;">Molecular Therapy—Methods & Clinical Development</em> is to build upon the success of <em style="user-select: text !important;">Molecular Therapy</em> in publishing important peer-reviewed methods and procedures, as well as translational advances in the broad array of fields under the molecular therapy umbrella.</p><p style="margin: 0px 0px 1.2em; line-height: 1.4em; color: rgb(51, 51, 51); font-family: arial, sans-serif; font-size: 13px; user-select: text !important;">Topics of particular interest within the journal''s scope include:</p><ul style="margin: 0px 0px 0px 20px; padding: 0px; color: rgb(51, 51, 51); font-family: arial, sans-serif; font-size: 13px; user-select: text !important;"><li style="user-select: text !important; line-height: 1.4em;">Gene vector engineering and production</li><li style="user-select: text !important; line-height: 1.4em;">Methods for targeted genome editing and engineering</li><li style="user-select: text !important; line-height: 1.4em;">Methods and technology development for cell reprogramming and directed differentiation of pluripotent cells</li><li style="user-select: text !important; line-height: 1.4em;">Methods for gene and cell vector delivery</li><li style="user-select: text !important; line-height: 1.4em;">Development of biomaterials and nanoparticles for applications in gene and cell therapy and regenerative medicine</li><li style="user-select: text !important; line-height: 1.4em;">Analysis of gene and cell vector biodistribution and tracking</li><li style="user-select: text !important; line-height: 1.4em;">Pharmacology/toxicology studies of new and next-generation vectors</li><li style="user-select: text !important; line-height: 1.4em;">Methods for cell isolation, engineering, culture, expansion, and transplantation</li><li style="user-select: text !important; line-height: 1.4em;">Cell processing, storage, and banking for therapeutic application</li><li style="user-select: text !important; line-height: 1.4em;">Preclinical and QC/QA assay development</li><li style="user-select: text !important; line-height: 1.4em;">Translational and clinical scale-up and Good Manufacturing procedures and process development</li><li style="user-select: text !important; line-height: 1.4em;">Clinical protocol development</li><li style="user-select: text !important; line-height: 1.4em;">Computational and bioinformatic methods for analysis, modeling, or visualization of biological data</li><li style="user-select: text !important; line-height: 1.4em;">Negotiating the regulatory approval process and obtaining such approval for clinical trials</li></ul>, totalCites=4825, brief=MOL THER-METH CLIN D杂志医学行业，暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般，也很冷门，关注人少，审稿周期可能也不一定快，如果文章质量不佳，或时间不紧的话，可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=d9e513096'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.82), GetImpactFactorCiteScoreListResponse(year=2018, citescore=37.26), GetImpactFactorCiteScoreListResponse(year=2019, citescore=6.2), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=3.996), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=4.585), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=3.343), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=2.527), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=1.947)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Genetics , rank=96/318), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Molecular Medicine , rank=61/165), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Molecular Biology , rank=141/375)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2329-0501[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Molecular Therapy-Methods & Clinical Development[ta], article_number=149, article_number_cn=9, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)